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This paper investigates the relationship between animal rabies
and postexposure treatment (PET) in Ontario by examining the
introduction of human diploid cell vaccine (HDCV) in 1980 and
the initiation of an oral rabies vaccination program for wildlife in
1989. Introducing HDCV led to an immediate doubling of treat-
ments. Both animal rabies and human treatments declined rap-
idly after the vaccination program was introduced, but human
treatments have leveled off at approximately 1,000 per year.
urisdictions across North America have identified animal
rabies as a serious public health concern (1,2) because the
epidemiology of human rabies closely follows the epizoology
of animal rabies (3). Recent studies have examined the rela-
tionship between animal rabies and postexposure treatment
(PET) for reasons of surveillance, economic impact, epidemi-
ology, and appropriate treatment (2,4,5). We investigated the
nature of this relationship in Ontario from 1958 to 2000,
focusing on the impact of two important advances in rabies
prevention: a) the introduction of human diploid cell rabies
vaccine (HDCV) and b) the initiation of an oral rabies vaccina-
tion program (ORVP).
Animal rabies has had a long and varied history in Ontario.
Before the 1950s, sporadic outbreaks of rabies occurred, usu-
ally associated with dogs. In the early 1950s, a rabies epizootic
swept southward from the Arctic, entered northern Ontario in
1954, and by 1958 became enzootic in southern Ontario in red
foxes (Vulpes vulpes) and striped skunks (Mephitis mephitis)
(6). Sylvatic rabies has, in turn, infected companion animals
and livestock, the two groups responsible for most subsequent
human exposures (Honig JM, unpub. data, 1985). In 1999, the
strain of raccoon rabies that has moved north along the eastern
seaboard of the United States entered eastern Ontario from
northern New York; by the end of 2000, there were 48 reported
cases in raccoons (8 during 1999; 40 during 2000) (7). Since
1958, Ontario has averaged 1,200 to 1,300 animal cases per
year, for a total of >56,000 cases by 2000. The burden on the
public health system has been substantial; for example,
>63,000 PETs were reported in the same period. In addition,
public health officials have had to investigate all contacts
between humans and animals in which rabies may have been
transmitted. In the 1980s, for example, at the height of the
rabies enzootic, 15,000 to 25,000 such investigations were car-
ried out annually (8).
In Canada, all animal rabies collection and laboratory
diagnoses are handled by the Canadian Food Inspection
Agency (CFIA), the federal ministry responsible for establish-
ing the collection protocols and the laboratory diagnosis of
submitted specimens that were suspected of carrying Rabies
virus  (RABV). District veterinary officers throughout the
country are responsible for specimen collection and the deci-
sion to send specimens to federally operated laboratories for
testing.
During the study period, Ontario’s Ministry of Health and
Long-Term Care (MOHLTC) distributed vaccine to physi-
cians, free of charge, for the prevention of human rabies. In the
fiscal year 1980-81, the ministry began distributing the newly
licensed HDCV to replace earlier Semple and duck embryo
vaccines. By the fiscal year 1983-84, all distributed vaccines
were HDCV (9). HDCV was an important advance in rabies
prevention because “it is a better immunogen with fewer side
effects and requires far fewer doses than the previously recom-
mended duck embryo vaccine” (10).
A second important advance in rabies prevention was
ORVP. In 1989, the Ontario Ministry of Natural Resources ini-
tiated an ORVP in eastern Ontario, targeting the principal
wildlife vectors (11). By 1994, the ministry had extended
ORVP to cover the epizootic area in southern Ontario, and
over 1 million vaccine baits were dropped annually. The pro-
gram resulted in a dramatic drop in rabies incidence in south-
ern Ontario (11). 
Methods
We gathered the PET and animal rabies data (Table) from
two government agencies. The MOHLTC annual reports from
1958 to 1978 list the number of courses of rabies vaccine dis-
tributed in each calendar year; for this paper, we considered
each such course as a PET. For 1979 to 1988 and 1998 to
2000, we obtained similar records directly from internal
reports in the MOHLTC. For 1989 to 1997, we obtained vac-
cine distribution data from the Public Health and Epidemiol-
ogy Reports for Ontario (12). We obtained the annual number
of laboratory-confirmed cases of animal rabies in Ontario
directly from CFIA. Data were compiled on all terrestrial ani-
mals and bats that tested positive for RABV. Data on the num-
ber of negative test results were not available. 
Our PET and rabies data were maintained for the entire
study period by two central government agencies with a con-
sistent mandate for collecting and reporting. Unfortunately,
because these two agencies operate independently, we could
not match the individual human treatments to the specific
specimens that tested positive for rabies.
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Human population data were obtained from Statistics Can-
ada Quarterly Estimates of Population for Canada, Provinces
and Territories, 1951-2000.
We used regression analysis to examine the relationship
between PET and the number of laboratory-confirmed cases of
rabies in terrestrial animals and bats in Ontario. Analyses were
done for the periods 1958 to 1980 and 1981 to 2000. As previ-
ously noted, HDCV was used during the second period. We
used SPSS (release 10.0.5, SPSS Inc., Chicago, IL) to perform
the regressions.
Results
From 1958 to 1980, the ratio of human treatments to ani-
mal cases was <1 in most years (Table, Figure). After HDCV
was introduced in 1980, the yearly ratios of human treatments
to animal cases were >1. Furthermore, from 1980 to 1981, the
rate of PET per 100,000 persons almost doubled. The annual
number of PETs increased from an average of approximately
1,000 in the 1970s to an average of more than 2,000 per year
during the 1980s. During the 1980s and early 1990s, the
annual number of PETs closely paralleled the annual number
of animal cases.
The regression for the 1958 to 1980 period showed a weak
but significant relationship between PET and animal rabies
(R2=0.42, p<0.001, n = 23, intercept = 557 [standard error, SE,
135.4], slope = 0.358 [SE 0.092]). After 1980 the relationship
was much stronger (R2=0.91, p<0.001, n = 20, intercept = 861
[SE 100.5], slope = 0.877 [SE 0.067]). The slopes of these
regressions indicate that before 1980, there were approxi-
mately three reports of rabid animals for every PET, whereas
after 1980, the ratio was approximately 1:1. Finally, the regres-
sion demonstrates that the base level of treatments after 1980
was 861, approximately 55% higher than the base level (557)
before 1980. 
Following the initiation of ORVP, the regular cycle of ani-
mal rabies was broken in the early 1990s (Figure) and the
number of laboratory-confirmed rabid animals declined. The
number of human treatments also declined by 50%, from more
than 2,000 per year throughout most of the 1980s to approxi-
mately 1,000 per year in the late 1990s.
Table. Rabies postexposure treatment (PET) and laboratory-
confirmed animal rabies, Ontario, 1958 to 2000
Year PET
Animal 
rabies
Ratio PET to 
animals rabies
PET rate per 
100,000a
1958 1,647 2,426 0.7 28.3
1959 479 1,210 0.4 8.0
1960 566 241 2.3 9.3
1961 790 636 1.2 12.7
1962 991 879 1.1 15.6
1963 965 907 1.1 14.9
1964 852 1,006 0.8 12.9
1965 1,367 1,352 1.0 20.2
1966 1,168 1,004 1.2 16.8
1967 1,461 1,232 1.2 20.5
1968 1,539 1,924 0.8 21.2
1969 1,187 2,154 0.6 16.1
1970 1,164 1,477 0.8 15.4
1971 960 1,428 0.7 12.4
1972 1,252 2,161 0.6 15.8
1973 1,020 1,503 0.7 12.7
1974 974 1,425 0.7 11.9
1975 1,050 1,954 0.5 12.6
1976 935 1,395 0.7 11.1
1977 957 1,267 0.8 11.3
1978 816 1,422 0.6 9.5
1979 1,002 1,480 0.7 12.0
1980 1,096 1,412 0.8 11.6
Average 1,054 1,387 0.8 14.3
1981 1,833 1,333 1.4 20.8
1982 2,402 2,095 1.1 27.0
1983 2,481 1,834 1.4 27.5
1984 2,027 1,366 1.5 22.1
1985 2,150 1,975 1.1 23.2
1986 4,212 3,274 1.3 44.7
1987 2,621 2,001 1.3 27.2
1988 2,266 1,830 1.2 23.1
1989 2,640 1,870 1.4 26.2
1990 1,991 1,611 1.2 19.4
1991 1,739 1,234 1.4 16.7
1992 2,186 1,371 1.6 20.7
1993 2,581 1,241 2.1 24.2
1994 1,437 613 2.3 13.3
1995 1,182 328 3.6 10.8
1996 937 149 6.3 8.5
1997 1,079 95 11.4 9.6
1998 1,048 80 13.1 9.2
1999 890 100 8.9 7.7
2000 1,073 183 5.9 9.2
 Average 1,939 1,229 1.6 19.0
aPopulation figures are from Statistics Canada Quarterly Estimates of Population for 
Canada, Provinces and Territories, 1951–2000.
Figure. Postexposure treatment (PET) and laboratory-confirmed animal
rabies. HDCV, human diploid cell vaccine; ORVP, oral rabies vaccina-
tion program; R2, coefficient of determination.DISPATCHES
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During the period 1968 to 1980, there was an apparent
change in the relationship between PET and animal rabies
compared with the initial 1958 to 1967 period of the enzootic
(Figure, Table). The ratios of PET per rabid animal and PET
rate per 100,000 persons for the 1958 to 1967 period were 0.9
and 16.0, respectively, and declined to mean values of 0.7 and
13.2, respectively, for the 1968 to 1980 period.
Discussion
There was a dramatic change in the relationship between
PET and animal rabies coincident with the introduction of
HDCV in 1980. Furthermore, after 1980, the positive correla-
tion between human treatments and animal rabies strength-
ened. We could not find any directives from the MOHLTC or
published studies indicating a change in treatment policy when
HDCV was introduced. Since HDCV had fewer side effects
and the vaccination regime was simpler and less traumatic
than previous treatments, there was, perhaps, less reluctance to
administer PET after 1980 and, therefore, the use of PET
increased and paralleled the incidence of animal rabies more
closely.
When Ontario began its ORVP, one of the arguments for it
was that animal rabies would be reduced and human treat-
ments would follow suit. Our findings support this argument
and are consistent with reports from other jurisdictions
(3,13,14). The decline in human treatments in Ontario, how-
ever, was not as rapid as the decline in rabies cases. In fact, in
recent years, while animal rabies incidence dropped to approx-
imately 100 to 200 reported cases per year, PET leveled off at
approximately 1,000 per year, about the same level as immedi-
ately before HDCV was introduced. We suspect the reasons
for the continued high ratio of PET to animal rabies are varied
and complex. For instance, with the continued presence of
rabies, if a suspect animal is not available for testing, PET is
administered as a precautionary measure. Furthermore, rabies
in bats has been unaffected by the ORVP. Bats have been
implicated in more than half (15 of 28 cases) of the human
rabies cases diagnosed in the United States since 1980 (15)
and in a recent death in Quebec (16). The recent spread of rac-
coon rabies from New York State into southeastern Ontario
has increased the media coverage of rabies and will contribute
to uncertainty about the presence of the RABV in the prov-
ince. Under these circumstances, with the relatively safe
HDCV, a continuing high number of treatments should be
expected. Even in the absence of further rabies cases, the
regression results suggest, at the 95% confidence interval,
annual treatments would range from 650 to 1,072 annually.
The decline in PET per rabid animal and PET rate per
100,000 persons in the 1968 to 1980 period hints at other fac-
tors affecting the relationship between animal rabies and the
administration of PET. We were unable to find any evidence in
published studies detailing a change of government policy
about the administration of PET or some traumatic event that
could initiate a de facto policy change. Indeed, studies during
that period recommended a treatment approach similar to
today’s guidelines (17). Furthermore, compulsory vaccination
of companion animals was not an explanation. Under the
Health Protection and Promotion Act, a regulation governing
rabies immunization was not introduced until 1984 and it has
taken until 2000 for all district health units in southern Ontario
to be included in it (18). All we know is that, early in this
period, rabies incidence across southern Ontario had stabilized
and developed regular cycles in various regions (19). We can
only speculate that, as animal rabies incidence became more
predictable, health professionals and the public learned to
manage the risk and there was less pressure to give PET, espe-
cially with older vaccines and their lengthy regime of injec-
tions. Experience in the United States indicated that
consultation with state health departments during management
of potential rabies exposure reduced PETs (10).
Conclusions
Our data suggest that human interventions have played a
major role in the relationship between PET and animal rabies.
The introduction of a new, safer vaccine was associated with a
sudden increase in the number of PETs per rabid animal. Fur-
thermore, while the introduction of an ORVP reduced animal
rabies, PET did not drop at a similar rate and has appeared to
stabilize at approximately 1,000 persons per year. This stabili-
zation, despite the diminishing number of rabies cases, is
important in estimating the economic impact of rabies control
and public education. However, as our data for the 1968 to
1980 period show, there are other, as-yet-unknown factors that
affect the animal rabies/PET relationship.
We believe that two general approaches are needed for the
future study of this complex relationship. First, we need details
of the circumstances of rabies incidents involving human
exposures, such as those assembled by Moran et al. (5), Honig
(unpub. data), and the Public Health Branch, Ministry of
Health (12). For Ontario, assembling these data will require
follow-up interviews on a case-by-case basis. Second, if we
can obtain data on the distribution of PETs by the 32 health
units in southern Ontario (we have distribution data for animal
rabies), we may gain further insight by (a) examining the dis-
tribution and interaction of human and animal populations; (b)
investigating the influence of the geographic scale at which the
relationships are examined; and (c) making regional compari-
sons of the administration of PET and the relative surveillance
efforts in an area over time, given the history of rabies inci-
dence and public awareness campaigns in the area.
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